Candesartan cilexetil CHARMing in chronic HF with low LVEF

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1467, 2004-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Candesartan cilexetil may prevent diabetes in patients with HF

By  

Inpharma, Vol. 1, Iss. 1495, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Low-dose candesartan cilexetil beneficial in CAD

By  

Inpharma, Vol. 1, Iss. 1419, 2004-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Candesartan cilexetil response in HF influenced by polymorphism?

By  

Inpharma, Vol. 1, Iss. 1648, 2008-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Candesartan Cilexetil: A Review of its Use In the Management of Chronic Heart Failure

By Caroline Fenton   Lesley J. Scott  

Drugs, Vol. 65, Iss. 4, 2005-01 ,pp. : 537-558

Adis International

Access to resources Recommend Favorite

Candesartan Cilexetil: A Pharmacoeconomic Review of its Use in Chronic Heart Failure and Hypertension

By Plosker Greg L.   Keam Susan J.  

PharmacoEconomics, Vol. 24, Iss. 12, 2006-01 ,pp. : 1249-1272

Adis International

Access to resources Recommend Favorite